Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Male & Female Healthy Volunteers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00839891
What this trial is testing

Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

Who this might be right for
Torsades de Pointes
VIVUS LLC 112
Early research (Phase 1)UnknownNCT02356419
What this trial is testing

RESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Who this might be right for
Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD. 40
Early research (Phase 1)Study completedNCT03318809
What this trial is testing

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

Who this might be right for
Heart Failure
Amgen 12
Early research (Phase 1)Ended earlyNCT02808052
What this trial is testing

Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency

Who this might be right for
Renal Insufficiency, AcuteRenal Insufficiency, ChronicHealthy Subjects
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 9
Early research (Phase 1)Study completedNCT04056455
What this trial is testing

Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Who this might be right for
Renal ImpairmentHealthy Volunteers
Millennium Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT05368935
What this trial is testing

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Who this might be right for
Renal ImpairmentRenal DiseaseKidney Disease
Genfit 77
Early research (Phase 1)Study completedNCT05418348
What this trial is testing

Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects

Who this might be right for
Aneurysmal Subarachnoid Hemorrhage
Grace Therapeutics Inc. 58
Early research (Phase 1)Study completedNCT06723535
What this trial is testing

Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Who this might be right for
Kidney Failure, ChronicHealthy VolunteersRenal Impairment
Bristol-Myers Squibb 27
Early research (Phase 1)Study completedNCT04273217
What this trial is testing

Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AbViro LLC 42
Early research (Phase 1)Study completedNCT05714254
What this trial is testing

Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Who this might be right for
Chronic Pain
AstraZeneca 36
Early research (Phase 1)Study completedNCT01129388
What this trial is testing

Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

Who this might be right for
Healthy
Sanofi 72
Early research (Phase 1)Study completedNCT02273531
What this trial is testing

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT00418002
What this trial is testing

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

Who this might be right for
Healthy
Novartis 72
Early research (Phase 1)Study completedNCT05471817
What this trial is testing

Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers
Bayer 20
Early research (Phase 1)Study completedNCT00850746
What this trial is testing

Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

Who this might be right for
Functional Dyspepsia
Astellas Pharma Inc 80
Early research (Phase 1)Study completedNCT02447367
What this trial is testing

Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers

Who this might be right for
LUTSBenign Prostatic HyperplasiaOveractive Bladder
Jeil Pharmaceutical Co., Ltd. 54
Early research (Phase 1)Study completedNCT05077436
What this trial is testing

Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects

Who this might be right for
Healthy
Vifor (International) Inc. 28
Early research (Phase 1)Study completedNCT00849134
What this trial is testing

First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.

Who this might be right for
Pain, Inflammatory
GlaxoSmithKline 25
Early research (Phase 1)Not Yet RecruitingNCT07470177
What this trial is testing

Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 24
Not applicableLooking for participantsNCT07359664
What this trial is testing

OCTA in Cardiovascular Disease and Healthy Controls

Who this might be right for
Patients With Cardiovascular DiseaseHealthy Participants
University of Erlangen-Nürnberg Medical School 64
Next Page